Neurocrine Biosciences, Inc.
NASDAQ: NBIX
$91.22
-$0.96 (-1.0%)
Closing price May 26, 2023
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
4 years ago
Last Updated: 3 years ago
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
4 years ago
Last Updated: 3 years ago
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and initiations seen on Monday include Amazon, Anthem, Constellation Brands, Hecla Mining, Nike, Overstock.com and UnitedHealth.
4 years ago
Last Updated: 3 years ago
Four top growth stocks could be great trades for the balance of 2018 and good to hold into the coming years as they all stand to have continued revenue growth and are solid players in their...
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
4 years ago
Last Updated: 3 years ago
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now and all have outstanding upside potential.
5 years ago
Last Updated: 3 years ago
While there is no guarantee that these four biotech companies are acquired, they are outstanding stocks to own in aggressive growth portfolios on their own.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS and Vertex Pharmaceuticals.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Avis Budget, Blue Apron, Chipotle Mexican Grill, Domino's, Northrop Grumman, Pepsico, Rio Tinto, T-Mobile and...
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Accenture, Ericsson, General Motors, Phillips 66, United Rentals, Urban Outfitters, Xerox and Yum Brands.
5 years ago
Last Updated: 3 years ago
After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. Here are four big opportunities for aggressive...
5 years ago
Last Updated: 3 years ago
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
5 years ago
Last Updated: 3 years ago
The equity markets have been putting in a grinding, sideways move since March 1st, and may be getting ready for a jump higher. Analysts at Jefferies have some picks to take advantage of the move...
6 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls on Friday include Celgene, Continental Resources, Hess, Renewable Energy, U.S. Bancorp and Zynga.
6 years ago
Last Updated: 3 years ago